iX Biopharma Ltd. (SG:42C) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
iX Biopharma Ltd. has announced the formation of a new Audit and Risk Committee by merging its Audit Committee and Risk Management Committee. This restructuring aims to streamline the roles and responsibilities of its board members, enhancing governance efficiency. Additionally, the company has reconstituted its board committees following the retirement of Independent Director Ms. Angeline Tham.
For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.
